| mRNA |
ciclosporin |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-05 |
| mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-05 |
| mRNA |
BRD-K80183349 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
8e-05 |
| mRNA |
AT13387 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
8e-05 |
| mRNA |
BRD1812 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0001 |
| mRNA |
elocalcitol |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0002 |
| mRNA |
BRD-K85133207 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0007 |
| mRNA |
BRD-K11533227 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0007 |
| mRNA |
Rapamycin |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0007 |
| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0008 |